Spandidos Publications Logo
  • About
    • About Spandidos
    • Aims and Scopes
    • Abstracting and Indexing
    • Editorial Policies
    • Reprints and Permissions
    • Job Opportunities
    • Terms and Conditions
    • Contact
  • Journals
    • All Journals
    • Oncology Letters
      • Oncology Letters
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • International Journal of Oncology
      • International Journal of Oncology
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • Molecular and Clinical Oncology
      • Molecular and Clinical Oncology
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • Experimental and Therapeutic Medicine
      • Experimental and Therapeutic Medicine
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • International Journal of Molecular Medicine
      • International Journal of Molecular Medicine
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • Biomedical Reports
      • Biomedical Reports
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • Oncology Reports
      • Oncology Reports
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • Molecular Medicine Reports
      • Molecular Medicine Reports
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • World Academy of Sciences Journal
      • World Academy of Sciences Journal
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • International Journal of Functional Nutrition
      • International Journal of Functional Nutrition
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • International Journal of Epigenetics
      • International Journal of Epigenetics
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • Medicine International
      • Medicine International
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
  • Articles
  • Information
    • Information for Authors
    • Information for Reviewers
    • Information for Librarians
    • Information for Advertisers
    • Conferences
  • Language Editing
Spandidos Publications Logo
  • About
    • About Spandidos
    • Aims and Scopes
    • Abstracting and Indexing
    • Editorial Policies
    • Reprints and Permissions
    • Job Opportunities
    • Terms and Conditions
    • Contact
  • Journals
    • All Journals
    • Biomedical Reports
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • Experimental and Therapeutic Medicine
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • International Journal of Epigenetics
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • International Journal of Functional Nutrition
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • International Journal of Molecular Medicine
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • International Journal of Oncology
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • Medicine International
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • Molecular and Clinical Oncology
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • Molecular Medicine Reports
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • Oncology Letters
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • Oncology Reports
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • World Academy of Sciences Journal
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
  • Articles
  • Information
    • For Authors
    • For Reviewers
    • For Librarians
    • For Advertisers
    • Conferences
  • Language Editing
Login Register Submit
  • This site uses cookies
  • You can change your cookie settings at any time by following the instructions in our Cookie Policy. To find out more, you may read our Privacy Policy.

    I agree
Search articles by DOI, keyword, author or affiliation
Search
Advanced Search
presentation
Experimental and Therapeutic Medicine
Join Editorial Board Propose a Special Issue
Print ISSN: 1792-0981 Online ISSN: 1792-1015
Journal Cover
February-2015 Volume 9 Issue 2

Full Size Image

Sign up for eToc alerts
Recommend to Library

Journals

International Journal of Molecular Medicine

International Journal of Molecular Medicine

International Journal of Molecular Medicine is an international journal devoted to molecular mechanisms of human disease.

International Journal of Oncology

International Journal of Oncology

International Journal of Oncology is an international journal devoted to oncology research and cancer treatment.

Molecular Medicine Reports

Molecular Medicine Reports

Covers molecular medicine topics such as pharmacology, pathology, genetics, neuroscience, infectious diseases, molecular cardiology, and molecular surgery.

Oncology Reports

Oncology Reports

Oncology Reports is an international journal devoted to fundamental and applied research in Oncology.

Experimental and Therapeutic Medicine

Experimental and Therapeutic Medicine

Experimental and Therapeutic Medicine is an international journal devoted to laboratory and clinical medicine.

Oncology Letters

Oncology Letters

Oncology Letters is an international journal devoted to Experimental and Clinical Oncology.

Biomedical Reports

Biomedical Reports

Explores a wide range of biological and medical fields, including pharmacology, genetics, microbiology, neuroscience, and molecular cardiology.

Molecular and Clinical Oncology

Molecular and Clinical Oncology

International journal addressing all aspects of oncology research, from tumorigenesis and oncogenes to chemotherapy and metastasis.

World Academy of Sciences Journal

World Academy of Sciences Journal

Multidisciplinary open-access journal spanning biochemistry, genetics, neuroscience, environmental health, and synthetic biology.

International Journal of Functional Nutrition

International Journal of Functional Nutrition

Open-access journal combining biochemistry, pharmacology, immunology, and genetics to advance health through functional nutrition.

International Journal of Epigenetics

International Journal of Epigenetics

Publishes open-access research on using epigenetics to advance understanding and treatment of human disease.

Medicine International

Medicine International

An International Open Access Journal Devoted to General Medicine.

Journal Cover
February-2015 Volume 9 Issue 2

Full Size Image

Sign up for eToc alerts
Recommend to Library

  • Article
  • Citations
    • Cite This Article
    • Download Citation
    • Create Citation Alert
    • Remove Citation Alert
    • Cited By
  • Similar Articles
    • Related Articles (in Spandidos Publications)
    • Similar Articles (Google Scholar)
    • Similar Articles (PubMed)
  • Download PDF
  • Download XML
  • View XML
Article

Effect of intensive insulin therapy on first-phase insulin secretion in newly diagnosed type 2 diabetic patients with a family history of the disease

  • Authors:
    • Qing Li
    • Luan Wang
    • Lin Xiao
    • Zhongchao Wang
    • Fang Wang
    • Xiaolong Yu
    • Shengli Yan
    • Yangang Wang
  • View Affiliations / Copyright

    Affiliations: Department of Clinical Laboratory, The First People's Hospital of Zibo City, Zibo, Shandong 255200, P.R. China, Department of Endocrinology, Stem Cell Research Center, The Affiliated Hospital of Medical College, Qingdao University, Qingdao, Shandong 266003, P.R. China, Biochemistry Office, Weifang Medical College, Weifang, Shandong 261042, P.R. China
  • Pages: 612-618
    |
    Published online on: December 8, 2014
       https://doi.org/10.3892/etm.2014.2114
  • Expand metrics +
Metrics: Total Views: 0 (Spandidos Publications: | PMC Statistics: )
Metrics: Total PDF Downloads: 0 (Spandidos Publications: | PMC Statistics: )
Cited By (CrossRef): 0 citations Loading Articles...

This article is mentioned in:



Abstract

Intensive insulin treatment is known to improve β‑cell function in the majority of patients with newly diagnosed type 2 diabetes mellitus (T2DM), and family history (FH) is known to be an important independent risk factor for T2DM. Thus, the aim of the present study was to investigate the difference in first‑phase insulin secretion and the effect of intensive insulin therapy on the improvement of β‑cell function between T2DM patients with and without a FH of diabetes. Patients with newly diagnosed T2DM and healthy controls were divided into groups according to their FH of diabetes. Improvement in β‑cell function was evaluated with an arginine stimulation test after two weeks of continuous subcutaneous insulin infusion (CSII). Compared with the control group, the level of fasting insulin and the homeostasis model assessment of insulin resistance (HOMA2‑IR) were higher in the DM group, while the homeostasis model assessment of β‑cell insulin secretion (HOMA2‑%β) and the first‑phase peak ratio were lower (P<0.05). In addition, the first‑phase peak ratio in the FH‑ control group was higher compared with that in the FH+ control group (P=0.023). Following CSII, all the patients achieved excellent blood glucose control in 6.2±3.6 days, without severe adverse effects. In the DM groups, the fasting insulin level and HOMA2‑IR were lower, while the HOMA2‑%β and first‑phase peak ratio were higher, when compared with the values prior to treatment, particularly in the FH‑ DM group. The HOMA2‑%β in the FH+ DM group was lower compared with the FH‑ DM group (P=0.027). Therefore, T2DM patients with and without a FH of the disease were shown to have a good response to CSII in the improvement of insulin resistance and β‑cell function; however, the improvements were less significant in patients with a FH compared with patients without a FH of diabetes.
View Figures

Figure 1

Figure 2

Figure 3

View References

1 

Polonsky KS, Sturis J and Bell GI: Seminars in medicine of the Beth Israel Hospital, Boston. Non-insulin dependent diabetes mellitus - a genetically programmed failure of the beta cell to compensate for insulin resistance. N Engl J Med. 334:777–783. 1996. View Article : Google Scholar : PubMed/NCBI

2 

Retnakaran R and Zinman B: Short-term intensified insulin treatment in type 2 diabetes: long-term effects on β-cell function. Diabetes Obes Metab. 14(Suppl 3): 161–166. 2012. View Article : Google Scholar

3 

Tian J, Wang J, Li Y, et al: Endothelial function in patients with newly diagnosed type 2 diabetes receiving early intensive insulin therapy. Am J Hypertens. 25:1242–1248. 2012.PubMed/NCBI

4 

Harrison LB, Adams-Huet B, Raskin P and Lingvay I: β-cell function preservation after 3.5 years of intensive diabetes therapy. Diabetes Care. 35:1406–1412. 2012. View Article : Google Scholar : PubMed/NCBI

5 

Fukui T and Hirano T: High-density lipoprotein subspecies between patients with type 1 diabetes and type 2 diabetes without/with intensive insulin therapy. Endocr J. 59:561–569. 2012. View Article : Google Scholar

6 

Chen A, Huang Z, Wan X, et al: Attitudes toward diabetes affect maintenance of drug-free remission in patients with newly diagnosed type 2 diabetes after short-term continuous subcutaneous insulin infusion treatment. Diabetes Care. 35:474–481. 2012. View Article : Google Scholar : PubMed/NCBI

7 

Fang D, Guan H, Liu J, et al: Early intensive insulin therapy attenuates the p38 pathway in the renal cortex and indices of nephropathy in diabetic rats. Endocr J. 59:81–90. 2012. View Article : Google Scholar

8 

Dailey G: Early and intensive therapy for management of hyperglycemia and cardiovascular risk factors in patients with type 2 diabetes. Clin Ther. 33:665–678. 2011. View Article : Google Scholar : PubMed/NCBI

9 

Holman RR, Paul SK, Bethel MA, Matthews DR and Neil HA: 10-year follow-up of intensive glucose control in type 2 diabetes. N Engl J Med. 359:1577–1589. 2008. View Article : Google Scholar : PubMed/NCBI

10 

Gaede P, Lund-Andersen H, Parving HH and Pedersen O: Effect of a multifactorial intervention on mortality in type 2 diabetes. N Engl J Med. 358:580–591. 2008. View Article : Google Scholar : PubMed/NCBI

11 

Hu Y, Li L, Xu Y, et al: Short-term intensive therapy in newly diagnosed type 2 diabetes partially restores both insulin sensitivity and β-cell function in subjects with long-term remission. Diabetes Care. 34:1848–1853. 2011. View Article : Google Scholar : PubMed/NCBI

12 

Shah PK, Mudaliar S, Chang AR, et al: Effects of intensive insulin therapy alone and in combination with pioglitazone on body weight, composition, distribution and liver fat content in patients with type 2 diabetes. Diabetes Obes Metab. 13:505–510. 2011. View Article : Google Scholar : PubMed/NCBI

13 

Weng J, Li Y, Xu W, et al: Effect of intensive insulin therapy on beta-cell function and glycaemic control in patients with newly diagnosed type 2 diabetes: a multicentre randomised parallel-group trial. Lancet. 371:1753–1760. 2008. View Article : Google Scholar : PubMed/NCBI

14 

Valdez R, Yoon PW, Liu T and Khoury MJ: Family history and prevalence of diabetes in the U.S. population: the 6-year results from the National Health and Nutrition Examination Survey (1999–2004). Diabetes Care. 30:2517–2522. 2007. View Article : Google Scholar : PubMed/NCBI

15 

Li P, Zhang JF, Li L, et al: The impact of a family history of type 2 diabetes on insulin secretion and insulin sensitivity in individuals with varying glucose tolerance. Am J Med Sci. 345:22–27. 2013. View Article : Google Scholar

16 

Xia Z, Wang Z, Cai Q, et al: Prevalence and risk factors of type 2 diabetes in the adults in Haikou city, Hainan island, China. Iran J Public Health. 42:222–230. 2013.PubMed/NCBI

17 

Oh YJ, Nam HK, Rhie YJ, Park SH and Lee KH: Low serum adiponectin levels in Korean children with a family history of type 2 diabetes mellitus. Horm Res Paediatr. 77:382–387. 2012. View Article : Google Scholar : PubMed/NCBI

18 

Das M, Pal S and Ghosh A: Family history of type 2 diabetes and prevalence of metabolic syndrome in adult Asian Indians. J Cardiovasc Dis Res. 3:104–108. 2012. View Article : Google Scholar : PubMed/NCBI

19 

Lambert M: ADA releases revisions to recommendations for standards of medical care in diabetes. Am Fam Physician. 85:514–515. 2012.PubMed/NCBI

20 

Bhowmik B, Diep LM, Munir SB, et al: HbA(1c) as a diagnostic tool for diabetes and pre-diabetes: the Bangladesh experience. Diabet Med. 30:e70–e77. 2013. View Article : Google Scholar

21 

Praveen EP, Sahoo J, Khurana ML, et al: Insulin sensitivity and β-cell function in normoglycemic offspring of individuals with type 2 diabetes mellitus: Impact of line of inheritance. Indian J Endocrinol Metab. 16:105–111. 2012. View Article : Google Scholar : PubMed/NCBI

22 

Zengi A, Ercan G, Caglayan O, et al: Increased oxidative DNA damage in lean normoglycemic offspring of type 2 diabetic patients. Exp Clin Endocrinol Diabetes. 119:467–471. 2011. View Article : Google Scholar : PubMed/NCBI

23 

Retnakaran R, Qi Y, Opsteen C, Vivero E and Zinman B: Initial short-term intensive insulin therapy as a strategy for evaluating the preservation of beta-cell function with oral antidiabetic medications: a pilot study with sitagliptin. Diabetes Obes Metab. 12:909–915. 2010. View Article : Google Scholar : PubMed/NCBI

24 

Opsteen C, Qi Y, Zinman B and Retnakaran R: Effect of short-term intensive insulin therapy on quality of life in type 2 diabetes. J Eval Clin Pract. 18:256–261. 2012. View Article : Google Scholar

25 

Chon S, Oh S, Kim SW, et al: The effect of early insulin therapy on pancreatic β-cell function and long-term glycemic control in newly diagnosed type 2 diabetic patients. Korean J Intern Med. 25:273–281. 2010. View Article : Google Scholar : PubMed/NCBI

26 

Li HQ, Wang BP, Deng XL, et al: Insulin improves β-cell function in glucose-intolerant rat models induced by feeding a high-fat diet. Metabolism. 60:1566–1574. 2011. View Article : Google Scholar : PubMed/NCBI

Zengi A, Ercan G, Caglayan O, et al: Increased oxidative DNA damage in lean normoglycemic offspring of type 2 diabetic patients. Exp Clin Endocrinol Diabetes. 119:467–471. 2011. View Article : Google Scholar : PubMed/NCBI

Related Articles

  • Abstract
  • View
  • Download
  • Twitter
Copy and paste a formatted citation
Spandidos Publications style
Li Q, Wang L, Xiao L, Wang Z, Wang F, Yu X, Yan S and Wang Y: Effect of intensive insulin therapy on first-phase insulin secretion in newly diagnosed type 2 diabetic patients with a family history of the disease. Exp Ther Med 9: 612-618, 2015.
APA
Li, Q., Wang, L., Xiao, L., Wang, Z., Wang, F., Yu, X. ... Wang, Y. (2015). Effect of intensive insulin therapy on first-phase insulin secretion in newly diagnosed type 2 diabetic patients with a family history of the disease. Experimental and Therapeutic Medicine, 9, 612-618. https://doi.org/10.3892/etm.2014.2114
MLA
Li, Q., Wang, L., Xiao, L., Wang, Z., Wang, F., Yu, X., Yan, S., Wang, Y."Effect of intensive insulin therapy on first-phase insulin secretion in newly diagnosed type 2 diabetic patients with a family history of the disease". Experimental and Therapeutic Medicine 9.2 (2015): 612-618.
Chicago
Li, Q., Wang, L., Xiao, L., Wang, Z., Wang, F., Yu, X., Yan, S., Wang, Y."Effect of intensive insulin therapy on first-phase insulin secretion in newly diagnosed type 2 diabetic patients with a family history of the disease". Experimental and Therapeutic Medicine 9, no. 2 (2015): 612-618. https://doi.org/10.3892/etm.2014.2114
Copy and paste a formatted citation
x
Spandidos Publications style
Li Q, Wang L, Xiao L, Wang Z, Wang F, Yu X, Yan S and Wang Y: Effect of intensive insulin therapy on first-phase insulin secretion in newly diagnosed type 2 diabetic patients with a family history of the disease. Exp Ther Med 9: 612-618, 2015.
APA
Li, Q., Wang, L., Xiao, L., Wang, Z., Wang, F., Yu, X. ... Wang, Y. (2015). Effect of intensive insulin therapy on first-phase insulin secretion in newly diagnosed type 2 diabetic patients with a family history of the disease. Experimental and Therapeutic Medicine, 9, 612-618. https://doi.org/10.3892/etm.2014.2114
MLA
Li, Q., Wang, L., Xiao, L., Wang, Z., Wang, F., Yu, X., Yan, S., Wang, Y."Effect of intensive insulin therapy on first-phase insulin secretion in newly diagnosed type 2 diabetic patients with a family history of the disease". Experimental and Therapeutic Medicine 9.2 (2015): 612-618.
Chicago
Li, Q., Wang, L., Xiao, L., Wang, Z., Wang, F., Yu, X., Yan, S., Wang, Y."Effect of intensive insulin therapy on first-phase insulin secretion in newly diagnosed type 2 diabetic patients with a family history of the disease". Experimental and Therapeutic Medicine 9, no. 2 (2015): 612-618. https://doi.org/10.3892/etm.2014.2114
Follow us
  • Twitter
  • LinkedIn
  • Facebook
About
  • Spandidos Publications
  • Careers
  • Cookie Policy
  • Privacy Policy
How can we help?
  • Help
  • Live Chat
  • Contact
  • Email to our Support Team